Skip to main content

Dexrazoxane Hydrochloride Injection Shortage

Last Updated: February 13, 2024
Status: Current

Products Affected - Description
    • Dexrazoxane injection, Eugia US, 250 mg, vial, 1 count, NDC 55150-0434-01
    • Dexrazoxane injection, Eugia US, 500 mg, vial, 1 count, NDC 55150-0437-01
    • Dexrazoxane injection, Fosun Pharma, 250 mg, vial, 1 count, NDC 72266-0235-01
    • Dexrazoxane injection, Fosun Pharma, 500 mg, vial, 1 count, NDC 72266-0101-01
Reason for the Shortage
    • Eugia did not provide a reason for the shortage.
    • Breckenridge discontinued dexrazoxane injection in September 2023.
    • Fosun did not provide a reason for the shortage.
    • Hikma has dexrazoxane injection available.
    • Information regarding Almaject product availability is forthcoming.
Available Products
    • Dexrazoxane injection, Hikma, 250 mg, vial, 1 count, NDC 00143-9247-01
    • Dexrazoxane injection, Hikma, 500 mg, vial, 1 count, NDC 00143-9248-01

Estimated Resupply Dates

    • Eugia has dexrazoxane 250 mg and 500 mg vials on intermittent back order and the company is releasing supplies as they become available.
    • Fosun has dexrazoxane 250 mg and 500 mg vials on back order and the company cannot estimate a release date.

Updated

Created February 13, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.